From October 1, 2023 to December 31, 2023, the company has repurchased 957,000 shares, representing 0.21% for $26.15 million. With this, the company has completed the repurchase of 9,846,000 shares, representing 2.19% for $304.77 million under the buyback announced on March 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.62 USD | -0.86% | -2.38% | -5.23% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.23% | 12.01B | |
+38.51% | 727B | |
+32.47% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.11% | 205B | |
-5.64% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.